Ongoing Projects
A Novel Regulatory Axis: Investigating the Role of Lactate-Mediated Epigenetic and 3D Genome Remodeling in Alternative Splicing in Hypoxic Breast Cancer
Project Type
External
Principal Investigator
Raghunath Chatterjee (Co-PI)
Funding Agency
ANRF
Start Date
01 May 2026
Duration
3 years
Sanctioned Amount
29,472,000.00
Response to 5-aza-2’-deoxycytidine (decitabine) therapy in activating fetal haemoglobin (HbF) among HbE/β-thalassemia patients: development of a machine learning based predictive model
Project Type
External
Principal Investigator
Raghunath Chatterjee
Funding Agency
ICMR
Start Date
11 Jan 2024
Duration
3 years
Sanctioned Amount
15,483,000.00
Biomarker identification : multi-omics approaches to differentiate between diabetic and non-diabetic kidney disease and identification of markers of progression in chronic kidney disease
Project Type
External
Principal Investigator
Raghunath Chatterjee (Co-PI)
Funding Agency
ICMR
Start Date
10 Jan 2024
Duration
3 years
Sanctioned Amount
22,795,000.00
miRNAs in regulating the cardinal histopathological features of Psoriasis and their role as molecular checkpoints in cell proliferation
Project Type
External
Principal Investigator
Raghunath Chatterjee
Funding Agency
ANRF
Start Date
01 May 2023
Duration
3 years
Sanctioned Amount
3,850,000.00
Completed Projects
No completed projects.
